A Phase I/II Study of HY05350 in Mesothelin(MSLN)-Positive Advanced Solid Tumors

Clinical trial NCT07083323 · RECRUITING

Trial details

NCT number: NCT07083323
Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2025-07-22
Primary completion: 2028-03-31
Enrollment: 262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.